Literature DB >> 17266078

Barriers in the management of glucocorticoid-induced osteoporosis.

Jenice Ria S Guzman-Clark1, Meika A Fang, Mary E Sehl, Laural Traylor, Theodore J Hahn.   

Abstract

OBJECTIVE: To determine present practice for the management of glucocorticoid-induced osteoporosis (GIOP) in veterans; to characterize provider knowledge, beliefs, and practice behaviors regarding management of GIOP; and to identify potential barriers and interventions in the management of GIOP.
METHODS: To characterize current management of GIOP in an academic veterans administration medical center, we conducted a retrospective chart review of 100 patients who were prescribed a 90-day supply of prednisone. To assess clinicians' knowledge of GIOP clinical guidelines and perceptions of GIOP management, primary care clinicians and subspecialists completed a questionnaire and participated in focus groups.
RESULTS: Chart review revealed that only 32 of 100 patients receiving long-term glucocorticoid treatment underwent bone mineral density testing, and only 32 patients were prescribed the recommended calcium supplements. Of the 23 providers who completed the questionnaire and participated in the focus groups, 4 correctly identified both the dose and duration of glucocorticoid use at which GIOP prevention measures should be instituted. Common GIOP management barriers cited by participants were lack of knowledge, having limited time during the clinic visit to address all problems, patient nonadherence, and system problems. The most commonly mentioned potential interventions were the use of computerized clinical reminders and patient education.
CONCLUSION: Clinicians frequently do not follow recommended guidelines for the management of GIOP. Improving the management of GIOP will likely require a fundamental redesigning of care processes for this disorder in order to overcome provider, patient-related, and system barriers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17266078     DOI: 10.1002/art.22462

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  16 in total

1.  Patterns of preventive health services in rheumatoid arthritis patients compared to a primary care patient population.

Authors:  Androniki Bili; Lisa L Schroeder; Lindsay J Ledwich; H Lester Kirchner; Eric D Newman; Mary Chester M Wasko
Journal:  Rheumatol Int       Date:  2010-03-27       Impact factor: 2.631

2.  Treatment of glucocorticoid-induced osteoporsis.

Authors:  Gherardo Mazziotti; Andrea Giustina; Ernesto Canalis; John P Bilezikian
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-02       Impact factor: 5.346

3.  Glucocorticoid-induced osteoporosis: treatment update and review.

Authors:  Lisa-Ann Fraser; Jonathan D Adachi
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-04       Impact factor: 5.346

4.  Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update.

Authors:  Yasuo Suzuki; Hajime Nawata; Satoshi Soen; Saeko Fujiwara; Hisanori Nakayama; Ikuko Tanaka; Keiichi Ozono; Akira Sagawa; Ryoichi Takayanagi; Hiroyuki Tanaka; Takami Miki; Naomi Masunari; Yoshiya Tanaka
Journal:  J Bone Miner Metab       Date:  2014-05-13       Impact factor: 2.626

5.  Cost-effectiveness of implementing guidelines for the treatment of glucocorticoid-induced osteoporosis in Japan.

Authors:  K Moriwaki; H Fukuda
Journal:  Osteoporos Int       Date:  2019-01-04       Impact factor: 4.507

6.  Measuring health-related quality of life (HRQOL) in osteoporotic males using the Male OPAQ.

Authors:  S L Solimeo; S L Silverman; A D Calderon; A Nguyen; D T Gold
Journal:  Osteoporos Int       Date:  2011-04-29       Impact factor: 4.507

Review 7.  Glucocorticoid-induced osteoporosis in rheumatic diseases.

Authors:  Rosa Maria Rodrigues Pereira; Jozélio Freire de Carvalho; Ernesto Canalis
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

8.  Use of a computerized order set to increase prescription of calcium and vitamin D supplementation in patients receiving glucocorticoids.

Authors:  Minna J Kohler; Matxalen Amezaga; James Drozd; Susan T Crowley; Barbara Gulanski; Daren R Anderson; Liana Fraenkel
Journal:  J Gen Intern Med       Date:  2013-02-13       Impact factor: 5.128

9.  Implementation of recommendations for prevention of glucocorticosteroid-induced osteoporosis in hospitalized patients.

Authors:  Tal Gazitt; Muna Elias; Joy Feld; Idit Lavi; Amir Haddad; Rema Bishara-Garzuzi; Muhanad Abu Elhija; Adi Kibari; Devy Zisman
Journal:  Clin Rheumatol       Date:  2021-06-22       Impact factor: 2.980

10.  Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy.

Authors:  Mir Sadat-Ali; Abdulmohsen H Alelq; Badar A Alshafei; Haifa A Al-Turki; Mohammed A Abujubara
Journal:  Ann Saudi Med       Date:  2009 May-Jun       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.